Record Information |
---|
Version | 5.0 |
---|
Status | Detected and Quantified |
---|
Creation Date | 2005-11-16 15:48:42 UTC |
---|
Update Date | 2023-05-30 20:56:01 UTC |
---|
HMDB ID | HMDB0000699 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | 1-Methylnicotinamide |
---|
Description | 1-Methylnicotinamide, also known as trigonellinamide or trigonellamide chloride, belongs to the class of organic compounds known as nicotinamides. These are heterocyclic aromatic compounds containing a pyridine ring substituted at position 3 by a carboxamide group. 1-Methylnicotinamide exists in all living species, ranging from bacteria to plants to humans. 1-Methylnicotinamide has been detected, but not quantified in, a few different foods, such as anatidaes (Anatidae), chickens (Gallus gallus), and domestic pigs (Sus scrofa domestica). This could make 1-methylnicotinamide a potential biomarker for the consumption of these foods. 1-Methylnicotinamide is a primary metabolite. Primary metabolites are metabolically or physiologically essential metabolites. They are directly involved in an organism’s growth, development or reproduction. Based on a literature review a significant number of articles have been published on 1-Methylnicotinamide. |
---|
Structure | InChI=1S/C7H8N2O/c1-9-4-2-3-6(5-9)7(8)10/h2-5H,1H3,(H-,8,10)/p+1 |
---|
Synonyms | Value | Source |
---|
1-Methyl nicotinamide | ChEBI | 1-Methylnicotinamide cation | ChEBI | 3-(Aminocarbonyl)-1-methylpyridinium | ChEBI | 3-Carbamoyl-1-methylpyridin-1-ium | ChEBI | N(1)-Methylnicotinamide | ChEBI | N-1-Methylnicotinamide | ChEBI | Trigonellinamide | ChEBI | 1-Methyl-3-carbamoylpyridinium | HMDB | 1-Methyl-3-carbamoylpyridinium cation | HMDB | 3-Amido-N-methylpyridinium: 1-methyl-3-pyridinecarboxamide | HMDB | 3-Carbamoyl-1-methyl-pyridinium | HMDB | I-methyl nicotinamide | HMDB | N'-methylnicotinamide | HMDB | N'Methylnicotinamide | HMDB | N-Methyl-3-carbamidopyridinium | HMDB | N-Methyl-3-carbamoylpyridinium ion | HMDB | N1-Methylnicotinamide | HMDB | N(1)-Methylnicotinamide chloride | HMDB | N(1)-Methylnicotinamide cyanide | HMDB | N(1)-Methylnicotinamide fluoride | HMDB | N(1)-Methylnicotinamide iodide, 3-(aminocarbonyl-13C)-labeled | HMDB | N(1)-Methylnicotinamide methylsulfate | HMDB | N(1)-Methylnicotinamide perchlorate | HMDB | N(1)-Methylnicotinamide bromide | HMDB | N(1)-Methylnicotinamide iodide | HMDB | N(1)-Methylnicotinamide tetrafluoroborate (1-) | HMDB | Trigonellamide chloride | HMDB |
|
---|
Chemical Formula | C7H9N2O |
---|
Average Molecular Weight | 137.1592 |
---|
Monoisotopic Molecular Weight | 137.07148792 |
---|
IUPAC Name | 3-carbamoyl-1-methylpyridin-1-ium |
---|
Traditional Name | 1-methylnicotinamide |
---|
CAS Registry Number | 3106-60-3 |
---|
SMILES | C[N+]1=CC=CC(=C1)C(N)=O |
---|
InChI Identifier | InChI=1S/C7H8N2O/c1-9-4-2-3-6(5-9)7(8)10/h2-5H,1H3,(H-,8,10)/p+1 |
---|
InChI Key | LDHMAVIPBRSVRG-UHFFFAOYSA-O |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as nicotinamides. These are heterocyclic aromatic compounds containing a pyridine ring substituted at position 3 by a carboxamide group. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Pyridines and derivatives |
---|
Sub Class | Pyridinecarboxylic acids and derivatives |
---|
Direct Parent | Nicotinamides |
---|
Alternative Parents | |
---|
Substituents | - Nicotinamide
- N-methylpyridinium
- Pyridinium
- Heteroaromatic compound
- Vinylogous amide
- Carboxamide group
- Primary carboxylic acid amide
- Carboxylic acid derivative
- Azacycle
- Organic nitrogen compound
- Organic oxygen compound
- Hydrocarbon derivative
- Organic oxide
- Organooxygen compound
- Organonitrogen compound
- Organopnictogen compound
- Organic cation
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | |
---|
Disposition | |
---|
Process | |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 855 mg/mL | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
1-Methylnicotinamide,1TMS,isomer #1 | C[N+]1=CC=CC(C(=O)N[Si](C)(C)C)=C1 | 1541.7 | Semi standard non polar | 33892256 | 1-Methylnicotinamide,1TMS,isomer #1 | C[N+]1=CC=CC(C(=O)N[Si](C)(C)C)=C1 | 1547.6 | Standard non polar | 33892256 | 1-Methylnicotinamide,1TMS,isomer #1 | C[N+]1=CC=CC(C(=O)N[Si](C)(C)C)=C1 | 1759.0 | Standard polar | 33892256 | 1-Methylnicotinamide,2TMS,isomer #1 | C[N+]1=CC=CC(C(=O)N([Si](C)(C)C)[Si](C)(C)C)=C1 | 1572.1 | Semi standard non polar | 33892256 | 1-Methylnicotinamide,2TMS,isomer #1 | C[N+]1=CC=CC(C(=O)N([Si](C)(C)C)[Si](C)(C)C)=C1 | 1601.0 | Standard non polar | 33892256 | 1-Methylnicotinamide,2TMS,isomer #1 | C[N+]1=CC=CC(C(=O)N([Si](C)(C)C)[Si](C)(C)C)=C1 | 1745.5 | Standard polar | 33892256 | 1-Methylnicotinamide,1TBDMS,isomer #1 | C[N+]1=CC=CC(C(=O)N[Si](C)(C)C(C)(C)C)=C1 | 1760.1 | Semi standard non polar | 33892256 | 1-Methylnicotinamide,1TBDMS,isomer #1 | C[N+]1=CC=CC(C(=O)N[Si](C)(C)C(C)(C)C)=C1 | 1716.8 | Standard non polar | 33892256 | 1-Methylnicotinamide,1TBDMS,isomer #1 | C[N+]1=CC=CC(C(=O)N[Si](C)(C)C(C)(C)C)=C1 | 1918.1 | Standard polar | 33892256 | 1-Methylnicotinamide,2TBDMS,isomer #1 | C[N+]1=CC=CC(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C1 | 2019.6 | Semi standard non polar | 33892256 | 1-Methylnicotinamide,2TBDMS,isomer #1 | C[N+]1=CC=CC(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C1 | 2000.8 | Standard non polar | 33892256 | 1-Methylnicotinamide,2TBDMS,isomer #1 | C[N+]1=CC=CC(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C1 | 1983.3 | Standard polar | 33892256 |
|
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - 1-Methylnicotinamide GC-MS (Non-derivatized) - 70eV, Positive | splash10-000i-5900000000-5a5fd45836c387d92371 | 2016-09-22 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 1-Methylnicotinamide GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - 1-Methylnicotinamide Quattro_QQQ 10V, Positive-QTOF (Annotated) | splash10-000i-0900000000-c99e0e70357eb6fa74bb | 2012-07-24 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 1-Methylnicotinamide Quattro_QQQ 25V, Positive-QTOF (Annotated) | splash10-0006-9000000000-93675f2b9efbaba4d471 | 2012-07-24 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 1-Methylnicotinamide Quattro_QQQ 40V, Positive-QTOF (Annotated) | splash10-0fvl-9000000000-b1e908db583e418c2545 | 2012-07-24 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 1-Methylnicotinamide LC-ESI-QQ (API3000, Applied Biosystems) 10V, Positive-QTOF | splash10-000i-0900000000-9c3104d60f21f6375b0c | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 1-Methylnicotinamide LC-ESI-QQ (API3000, Applied Biosystems) 20V, Positive-QTOF | splash10-000i-1900000000-e500f262d42edb9b3ad7 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 1-Methylnicotinamide LC-ESI-QQ (API3000, Applied Biosystems) 30V, Positive-QTOF | splash10-0006-9200000000-496b2cf62a07bea4f746 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 1-Methylnicotinamide LC-ESI-QQ (API3000, Applied Biosystems) 40V, Positive-QTOF | splash10-002f-9000000000-a17b3a63979577f6fa9e | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 1-Methylnicotinamide LC-ESI-QQ (API3000, Applied Biosystems) 50V, Positive-QTOF | splash10-00ou-9000000000-46a856cd097a7a14dc90 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 1-Methylnicotinamide LC-ESI-QTOF (UPLC Q-Tof Premier, Waters) , Positive-QTOF | splash10-000l-6900000000-360fb882a925f7e9edc9 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 1-Methylnicotinamide LC-ESI-QTOF (UPLC Q-Tof Premier, Waters) 30V, Positive-QTOF | splash10-0006-9000000000-babd4e89db309a5c74cf | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 1-Methylnicotinamide LC-ESI-QQ , positive-QTOF | splash10-000i-0900000000-9c3104d60f21f6375b0c | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 1-Methylnicotinamide LC-ESI-QQ , positive-QTOF | splash10-000i-1900000000-e500f262d42edb9b3ad7 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 1-Methylnicotinamide LC-ESI-QQ , positive-QTOF | splash10-0006-9200000000-052c844f974abba065eb | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 1-Methylnicotinamide LC-ESI-QQ , positive-QTOF | splash10-002f-9000000000-a17b3a63979577f6fa9e | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 1-Methylnicotinamide LC-ESI-QQ , positive-QTOF | splash10-00ou-9000000000-2fe6c195129f32a62a3c | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 1-Methylnicotinamide LC-ESI-QTOF , positive-QTOF | splash10-000l-6900000000-360fb882a925f7e9edc9 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 1-Methylnicotinamide LC-ESI-QTOF , positive-QTOF | splash10-0006-9000000000-babd4e89db309a5c74cf | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 1-Methylnicotinamide , positive-QTOF | splash10-000i-0900000000-08a578fa81c8d41a4fe6 | 2017-09-14 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 1-Methylnicotinamide 10V, Positive-QTOF | splash10-000i-0900000000-d889aade6d1014ffb393 | 2016-09-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 1-Methylnicotinamide 20V, Positive-QTOF | splash10-004r-1900000000-8052aba6067c868e594f | 2016-09-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 1-Methylnicotinamide 40V, Positive-QTOF | splash10-00di-9500000000-579bc8310420ec3d8786 | 2016-09-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 1-Methylnicotinamide 10V, Negative-QTOF | splash10-000i-0900000000-141e3a418b748abf9e1d | 2016-09-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 1-Methylnicotinamide 20V, Negative-QTOF | splash10-000i-1900000000-33499eeb5abff5a8b53b | 2016-09-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 1-Methylnicotinamide 40V, Negative-QTOF | splash10-0006-9100000000-e45f804a013c97310f00 | 2016-09-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 1-Methylnicotinamide 10V, Positive-QTOF | splash10-000i-2900000000-5527bd16347dfbb8af1b | 2021-09-21 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Experimental 1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, experimental) | 2012-12-04 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Experimental 1D NMR | 13C NMR Spectrum (1D, 400 MHz, H2O, experimental) | 2021-10-10 | Wishart Lab | View Spectrum | Experimental 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, H2O, experimental) | 2012-12-05 | Wishart Lab | View Spectrum |
|
---|
Biological Properties |
---|
Cellular Locations | |
---|
Biospecimen Locations | |
---|
Tissue Locations | |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Detected and Quantified | 0.430 (0.007-0.850) uM | Adult (>18 years old) | Both | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Urine | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Urine | Detected and Quantified | 7.749 +/- 7.16 umol/mmol creatinine | Children (1 - 13 years old) | Not Specified | Normal | | details | Urine | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Urine | Detected and Quantified | 0.82 (0.26-2.3) umol/mmol creatinine | Newborn (0-30 days old) | Both | Normal | | details | Urine | Detected and Quantified | 1.9 (0.67-5.1) umol/mmol creatinine | Children (1-13 years old) | Both | Normal | | details | Urine | Detected and Quantified | 3.5 (1.3-6.0) umol/mmol creatinine | Adult (>18 years old) | Male | Normal | | details | Urine | Detected and Quantified | 4.8 (1.86-13.94) umol/mmol creatinine | Adult (>18 years old) | Female | Normal | | details | Urine | Detected and Quantified | 6.105 (0.240-12.0) umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details | Urine | Detected and Quantified | 2.5 (2.1-2.8) umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details | Urine | Detected and Quantified | 5.8 (1.2-15.0) umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details | Urine | Detected and Quantified | 61.37 (40.64-92.98) umol/mmol creatinine | Newborn (0-30 days old) | Both | Normal | | details |
|
---|
Abnormal Concentrations |
---|
| |
Blood | Detected and Quantified | 0.099-0.851 uM | Adult (>18 years old) | Both | Cirrhosis | | details | Urine | Detected and Quantified | 7.426 +/- 3.509 umol/mmol creatinine | Children (1 - 13 years old) | Not Specified | Eosinophilic esophagitis | | details | Urine | Detected and Quantified | 3.0 (0.0-14.0) umol/mmol creatinine | Adult (>18 years old) | Both | Lung cancer | | details | Urine | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Autosomal dominant polycystic kidney disease (ADPKD) | | details | Urine | Detected and Quantified | 37.00 (11.5-62.7) umol/mmol creatinine | Adult (>18 years old) | Both | Pellagra | | details |
|
---|
Associated Disorders and Diseases |
---|
Disease References | Cirrhosis |
---|
- Somogyi A, Siebert D, Bochner F: Determination of endogenous concentrations of N1-methylnicotinamide in human plasma and urine by high-performance liquid chromatography. Anal Biochem. 1990 May 15;187(1):160-5. [PubMed:2142586 ]
| Lung Cancer |
---|
- Stretch C, Eastman T, Mandal R, Eisner R, Wishart DS, Mourtzakis M, Prado CM, Damaraju S, Ball RO, Greiner R, Baracos VE: Prediction of skeletal muscle and fat mass in patients with advanced cancer using a metabolomic approach. J Nutr. 2012 Jan;142(1):14-21. doi: 10.3945/jn.111.147751. Epub 2011 Dec 7. [PubMed:22157537 ]
| Pellagra |
---|
- Creeke PI, Dibari F, Cheung E, van den Briel T, Kyroussis E, Seal AJ: Whole blood NAD and NADP concentrations are not depressed in subjects with clinical pellagra. J Nutr. 2007 Sep;137(9):2013-7. [PubMed:17709435 ]
| Autosomal dominant polycystic kidney disease |
---|
- Gronwald W, Klein MS, Zeltner R, Schulze BD, Reinhold SW, Deutschmann M, Immervoll AK, Boger CA, Banas B, Eckardt KU, Oefner PJ: Detection of autosomal dominant polycystic kidney disease by NMR spectroscopic fingerprinting of urine. Kidney Int. 2011 Jun;79(11):1244-53. doi: 10.1038/ki.2011.30. Epub 2011 Mar 9. [PubMed:21389975 ]
| Eosinophilic esophagitis |
---|
- Slae, M., Huynh, H., Wishart, D.S. (2014). Analysis of 30 normal pediatric urine samples via NMR spectroscopy (unpublished work). NA.
|
|
---|
Associated OMIM IDs | - 211980 (Lung Cancer)
- 601313 (Autosomal dominant polycystic kidney disease)
- 610247 (Eosinophilic esophagitis)
|
---|
External Links |
---|
DrugBank ID | DB11710 |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | FDB022188 |
---|
KNApSAcK ID | C00052106 |
---|
Chemspider ID | 444 |
---|
KEGG Compound ID | C02918 |
---|
BioCyc ID | CPD-396 |
---|
BiGG ID | 2226225 |
---|
Wikipedia Link | 1-Methylnicotinamide |
---|
METLIN ID | 5667 |
---|
PubChem Compound | 457 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 16797 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | 1MNCAM |
---|
MarkerDB ID | MDB00000225 |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Nelis, Hans J. C. F.; Airy, Subhash C.; Sinsheimer, J. E. Comparison of the alkylation of nicotinamide and 4-(p-nitrobenzyl)pyridine for the determination of aliphatic epoxides. Analytical Chemistry (1982), 54(2), 213-16. |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | - Ohdoi C, Nyhan WL, Kuhara T: Chemical diagnosis of Lesch-Nyhan syndrome using gas chromatography-mass spectrometry detection. J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Jul 15;792(1):123-30. [PubMed:12829005 ]
- Pelletier O, Brassard R: Automated and manual determination of N1-methylnicotinamide in urine. Am J Clin Nutr. 1977 Dec;30(12):2108-16. [PubMed:145178 ]
- Carter EG: Quantitation of urinary niacin metabolites by reversed-phase liquid chromatography. Am J Clin Nutr. 1982 Nov;36(5):926-30. [PubMed:6215856 ]
- Slominska EM, Smolenski RT, Szolkiewicz M, Leaver N, Rutkowski B, Simmonds HA, Swierczynski J: Accumulation of plasma N-methyl-2-pyridone-5-carboxamide in patients with chronic renal failure. Mol Cell Biochem. 2002 Feb;231(1-2):83-8. [PubMed:11952169 ]
- Patterson JI, Brown RR, Linkswiler H, Harper AE: Excretion of tryptophan-niacin metabolites by young men: effects of tryptophan, leucine, and vitamin B6 intakes. Am J Clin Nutr. 1980 Oct;33(10):2157-67. [PubMed:6448542 ]
- Musfeld C, Biollaz J, Belaz N, Kesselring UW, Decosterd LA: Validation of an HPLC method for the determination of urinary and plasma levels of N1-methylnicotinamide, an endogenous marker of renal cationic transport and plasma flow. J Pharm Biomed Anal. 2001 Jan;24(3):391-404. [PubMed:11199218 ]
- Wozniacka A, Wieczorkowska M, Gebicki J, Sysa-Jedrzejowska A: Topical application of 1-methylnicotinamide in the treatment of rosacea: a pilot study. Clin Exp Dermatol. 2005 Nov;30(6):632-5. [PubMed:16197374 ]
- Chlopicki S, Swies J, Mogielnicki A, Buczko W, Bartus M, Lomnicka M, Adamus J, Gebicki J: 1-Methylnicotinamide (MNA), a primary metabolite of nicotinamide, exerts anti-thrombotic activity mediated by a cyclooxygenase-2/prostacyclin pathway. Br J Pharmacol. 2007 Sep;152(2):230-9. Epub 2007 Jul 16. [PubMed:17641676 ]
- Elshenawy S, Pinney SE, Stuart T, Doulias PT, Zura G, Parry S, Elovitz MA, Bennett MJ, Bansal A, Strauss JF 3rd, Ischiropoulos H, Simmons RA: The Metabolomic Signature of the Placenta in Spontaneous Preterm Birth. Int J Mol Sci. 2020 Feb 4;21(3). pii: ijms21031043. doi: 10.3390/ijms21031043. [PubMed:32033212 ]
|
---|